Michie (Mei Kuen) Ong WuXi Advanced Therapies

Michie leads a diverse team of quality professionals and is responsible for the quality system, operations, and compliance of WuXi Advanced Therapies’ Philadelphia site. The Philadelphia campus boasts over 400,000 ft2 of facilities and 800 employees dedicated to the development, testing, and clinical and commercial manufacturing of cell and gene therapies. Prior to joining WuXi Advanced Therapies, Michie spent 16 years in Genentech and Roche focused on quality assurance, quality systems, compliance audit, health authority inspection, and lean manufacturing in different geographies. Her track record includes proven success leading pre-licensure inspections (PLI), pre-approval inspections (PAI) and routine inspections. Michie earned a Bachelor of Science in Biotechnology from the University of Monash, Australia. After graduation, she spent four years as a Research Assistant in the laboratories at the Department of Toxicology in the National University of Singapore.